EyePoint Pharmaceuticals
EYPT
EYPT
32 hedge funds and large institutions have $50.7M invested in EyePoint Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-18
Holders Change %
-36%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
9
Reduced
12
Closed
26
Calls
$240K
Puts
$14K
Net Calls
+$226K
Net Calls Change
+$223K
Top Buyers
Top Sellers
1 |
BlackRock
New York
|
$662K |
2 |
Morgan Stanley
New York
|
$13K |
3 |
UBS Group
Zurich,
Switzerland
|
$3K |
4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
$355K |
5 |
Wells Fargo
San Francisco,
California
|
$15K |